Article
Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
Oncotarget - 22 Mar 2016
Cao Lei, Wang Hui-Fu, Tan Lin, Sun Fu-Rong, Tan Meng-Shan, Tan Chen-Chen, Jiang Teng, Yu Jin-Tai, Tan Lan
Abstract excerpt
Alzheimer's disease (AD) has become a considerable public health issue. The mechanisms underlying AD onset and progression remain largely unclear. 3-Hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) is a strong functional AD candidate gene because it encodes part of the statin-binding domain of the enzyme, which serves as the rate-limiting step in cholesterol synthesis in all mammalian cells. Here, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
